Search Results - "Hartnett, M Elizabeth"

Refine Results
  1. 1

    Pathophysiology and Mechanisms of Severe Retinopathy of Prematurity by Hartnett, M. Elizabeth, MD

    Published in Ophthalmology (Rochester, Minn.) (01-01-2015)
    “…Retinopathy of prematurity (ROP) affects only premature infants, but as premature births increase in many areas of the world, ROP has become a leading cause of…”
    Get full text
    Journal Article
  2. 2

    Mechanisms and Management of Retinopathy of Prematurity by Hartnett, M. Elizabeth, Penn, John S

    Published in The New England journal of medicine (27-12-2012)
    “…This article reviews retinopathy of prematurity, particularly regarding oxygen use, and describes current and potential therapies based on mechanistic studies…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Regulation of signaling events involved in the pathophysiology of neovascular AMD by Wang, Haibo, Hartnett, M Elizabeth

    Published in Molecular vision (27-02-2016)
    “…Neovascular age-related macular degeneration (AMD) is a complex disease in which an individual's genetic predisposition is affected by aging and environmental…”
    Get full text
    Journal Article
  7. 7

    RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity by Ramshekar, Aniket, Bretz, Colin A, Hartnett, M Elizabeth

    “…The pathophysiology of retinopathy of prematurity (ROP) is postulated to first involve delayed intraretinal vascularization, followed by intravitreal…”
    Get full text
    Journal Article
  8. 8

    7-ketocholesterol induces endothelial-mesenchymal transition and promotes fibrosis: implications in neovascular age-related macular degeneration and treatment by Wang, Haibo, Ramshekar, Aniket, Kunz, Eric, Hartnett, M. Elizabeth

    Published in Angiogenesis (London) (01-08-2021)
    “…Oxidized cholesterols and lipids accumulate in Bruch’s membrane in age-related macular degeneration (AMD). It remains unknown what causal relationship exists…”
    Get full text
    Journal Article
  9. 9

    Laser versus Anti-VEGF: A Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity by Hartnett, M. Elizabeth, Stahl, Andreas

    Published in Ophthalmology and therapy (01-10-2023)
    “…Retinopathy of prematurity (ROP), a leading cause of childhood blindness, has historically been associated with blindness from overgrowth of blood vessels from…”
    Get full text
    Journal Article
  10. 10

    Vascular Endothelial Growth Factor Antagonist Therapy for Retinopathy of Prematurity by Hartnett, M. Elizabeth, MD

    Published in Clinics in perinatology (01-12-2014)
    “…In this article, the growing problem of retinopathy of prematurity (ROP) worldwide, treatments for severe ROP including standard-of-care laser treatment, and…”
    Get full text
    Journal Article
  11. 11

    Thy-1 Regulates VEGF-Mediated Choroidal Endothelial Cell Activation and Migration: Implications in Neovascular Age-Related Macular Degeneration by Wang, Haibo, Han, Xiaokun, Kunz, Eric, Hartnett, M Elizabeth

    “…This study addresses the hypothesis that age-related stresses upregulate Thy-1 in choroidal endothelial cells (CECs) and contribute to CEC activation and…”
    Get full text
    Journal Article
  12. 12

    Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity by Ramshekar, Aniket, Hartnett, M Elizabeth

    Published in Frontiers in pediatrics (09-12-2021)
    “…Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide. Blindness can occur from retinal detachment caused by pathologic…”
    Get full text
    Journal Article
  13. 13

    The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model by Elizabeth Hartnett, M.

    Published in Documenta ophthalmologica (01-02-2010)
    “…The objective of this study is to determine growth factor expression and activation of signaling pathways associated with intravitreous neovascularization and…”
    Get full text
    Journal Article
  14. 14

    Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms by Becker, Silke, Wang, Haibo, Simmons, Aaron B., Suwanmanee, Thipparat, Stoddard, Gregory J., Kafri, Tal, Hartnett, M. Elizabeth

    Published in Scientific reports (31-01-2018)
    “…Oxygen-induced retinopathy (OIR) upregulates Müller cell vascular endothelial growth factor A (VEGFA) that causes intravitreal neovascularization similar to…”
    Get full text
    Journal Article
  15. 15

    The Effects of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Erythropoietin, and Their Interactions in Angiogenesis: Implications in Retinopathy of Prematurity by Cung, Thaonhi, Wang, Haibo, Hartnett, M. Elizabeth

    Published in Cells (Basel, Switzerland) (17-06-2022)
    “…Retinopathy of prematurity (ROP) is a leading cause of vision impairment and blindness in premature infants. Oxidative stress is implicated in its…”
    Get full text
    Journal Article
  16. 16

    Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity by McCloskey, Manabu, Wang, Haibo, Jiang, Yanchao, Smith, George Wesley, Strange, Jeremy, Hartnett, M Elizabeth

    “…Inhibiting VEGF improves adult retino/choroido-vascular diseases, but can lead to recurrent intravitreous neovascularization (IVNV), avascular retina (AVA),…”
    Get full text
    Journal Article
  17. 17

    Effects of oxygen on the development and severity of retinopathy of prematurity by Hartnett, M. Elizabeth, MD, Lane, Robert H., MD, MS

    Published in Journal of AAPOS (01-06-2013)
    “…Summary In 1942, when retinopathy of prematurity (ROP) first manifested as retrolental fibroplasia, the technology to monitor or regulate oxygen did not exist,…”
    Get full text
    Journal Article
  18. 18

    The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial by Addo, Emmanuel K, Hartnett, M Elizabeth, Bernstein, Paul S

    “…Age-related macular degeneration (AMD) is an irreversible blinding eye condition with complex genetic and environmental etiologies. Genetic testing for AMD for…”
    Get full text
    Journal Article
  19. 19
  20. 20